These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 11166521)

  • 21. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of 5-HT receptor antagonists in mediating intracavernous pressure response induced by fluvoxamine in conscious rats.
    Aizawa N; Ishizuka O; Ogawa T; Mizusawa H; Igawa Y; Nishizawa O
    J Sex Med; 2007 Jul; 4(4 Pt 2):1108-16. PubMed ID: 17627723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.
    Zaniewska M; McCreary AC; Filip M
    Synapse; 2009 Aug; 63(8):653-61. PubMed ID: 19347958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.
    De Deurwaerdère P; Spampinato U
    J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.
    Maura G; Marcoli M; Pepicelli O; Rosu C; Viola C; Raiteri M
    Br J Pharmacol; 2000 Aug; 130(8):1853-8. PubMed ID: 10952674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP.
    Durand M; Mormède P; Chaouloff F
    Behav Pharmacol; 2003 Mar; 14(2):173-7. PubMed ID: 12658079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.
    Clenet F; De Vos A; Bourin M
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):145-52. PubMed ID: 11313160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.
    Fletcher PJ; Sinyard J; Higgins GA
    Psychopharmacology (Berl); 2006 Sep; 187(4):515-25. PubMed ID: 16832658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
    Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
    Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
    McCreary AC; Filip M; Cunningham KA
    Behav Neurosci; 2003 Apr; 117(2):212-21. PubMed ID: 12708517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.
    Nic Dhonnchadha BA; Ripoll N; Clénet F; Hascoët M; Bourin M
    Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.
    Gobert A; Rivet JM; Lejeune F; Newman-Tancredi A; Adhumeau-Auclair A; Nicolas JP; Cistarelli L; Melon C; Millan MJ
    Synapse; 2000 Jun; 36(3):205-21. PubMed ID: 10819900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.
    Sotty F; Folgering JH; Brennum LT; Hogg S; Mørk A; Hertel P; Cremers TI
    Neuropharmacology; 2009 Jul; 57(1):18-24. PubMed ID: 19376075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
    Halberstadt AL; van der Heijden I; Ruderman MA; Risbrough VB; Gingrich JA; Geyer MA; Powell SB
    Neuropsychopharmacology; 2009 Jul; 34(8):1958-67. PubMed ID: 19322172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
    Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
    Bromidge SM; Dabbs S; Davies DT; Davies S; Duckworth DM; Forbes IT; Gaster LM; Ham P; Jones GE; King FD; Mulholland KR; Saunders DV; Wyman PA; Blaney FE; Clarke SE; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Trail B; Riley GJ; Wood MD
    J Med Chem; 2000 Mar; 43(6):1123-34. PubMed ID: 10737744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.